Co-expression and modulation of neuronal and endothelial nitric oxide synthase in human endothelial cells

Tiziana Bachetti, Laura Comini, Salvatore Curello, Daniela Bastianon, Michela Palmieri, Giuliana Bresciani, Francesco Callea, Roberto Ferrari

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Despite originally identified in neurones, the neuronal type of nitric oxide synthase (nNOS) is present also in cardiac and skeletal myocytes. Whether nNOS is functionally expressed in human endothelial cells - as the endothelial enzyme (eNOS) - is unknown. Human umbilical vein endothelial cells (HUVEC) were studied under control culture conditions and after 48 h treatment with cytomix (human tumour necrosis factor-α, interferon-γ and E. coli endotoxin). We tested: (i) localisation and expression of nNOS and eNOS proteins by immunostaining and immunoblotting; (ii) activity of nNOS and eNOS by measuring l-arginine to l-citrulline conversion with 1-(2-trifluoromethylphenyl) imidazole (TRIM), a specific nNOS antagonist, in sub-cellular fractions; (iii) intracellular cGMP levels, as a marker for nitric oxide production, after TRIM pre-treatment, by radioimmunoassay. nNOS protein was expressed in the cytosolic fraction and immunolocalised in cultured HUVEC, and co-localised with the eNOS protein in frozen sections of the human umbilical cord. nNOS protein contributed to total l-citrulline production as TRIM selectively and dose-dependently reduced l-citrulline synthesis in the cytosolic but not particulate fraction of HUVEC. Similarly, TRIM reduced intracellular cGMP content both at baseline and after stimulation with a calcium ionophore. Cytomix down-regulated the expression and function of both nNOS and eNOS while no inducible NOS (iNOS) was detected. In conclusion, a functional neuronal type of NOS is co-expressed with the endothelial NOS type in HUVEC, suggesting a possible role for nNOS in regulation of blood flow.

Original languageEnglish
Pages (from-to)939-945
Number of pages7
JournalJournal of Molecular and Cellular Cardiology
Volume37
Issue number5
DOIs
Publication statusPublished - Nov 2004

Fingerprint

Nitric Oxide Synthase Type I
Nitric Oxide Synthase Type III
Endothelial Cells
Human Umbilical Vein Endothelial Cells
Citrulline
Proteins
Calcium Ionophores
Umbilical Cord
Skeletal Muscle Fibers
Frozen Sections
Immunoblotting
Cardiac Myocytes
Endotoxins
Interferons
Radioimmunoassay
Arginine
Nitric Oxide
Escherichia coli
Neurons

Keywords

  • Cell culture/isolation
  • Cytokines
  • Endothelial factors
  • Infection/inflammation
  • Nitric oxide

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Co-expression and modulation of neuronal and endothelial nitric oxide synthase in human endothelial cells. / Bachetti, Tiziana; Comini, Laura; Curello, Salvatore; Bastianon, Daniela; Palmieri, Michela; Bresciani, Giuliana; Callea, Francesco; Ferrari, Roberto.

In: Journal of Molecular and Cellular Cardiology, Vol. 37, No. 5, 11.2004, p. 939-945.

Research output: Contribution to journalArticle

Bachetti, Tiziana ; Comini, Laura ; Curello, Salvatore ; Bastianon, Daniela ; Palmieri, Michela ; Bresciani, Giuliana ; Callea, Francesco ; Ferrari, Roberto. / Co-expression and modulation of neuronal and endothelial nitric oxide synthase in human endothelial cells. In: Journal of Molecular and Cellular Cardiology. 2004 ; Vol. 37, No. 5. pp. 939-945.
@article{87c5e468716b459996953d3a3a92d4fd,
title = "Co-expression and modulation of neuronal and endothelial nitric oxide synthase in human endothelial cells",
abstract = "Despite originally identified in neurones, the neuronal type of nitric oxide synthase (nNOS) is present also in cardiac and skeletal myocytes. Whether nNOS is functionally expressed in human endothelial cells - as the endothelial enzyme (eNOS) - is unknown. Human umbilical vein endothelial cells (HUVEC) were studied under control culture conditions and after 48 h treatment with cytomix (human tumour necrosis factor-α, interferon-γ and E. coli endotoxin). We tested: (i) localisation and expression of nNOS and eNOS proteins by immunostaining and immunoblotting; (ii) activity of nNOS and eNOS by measuring l-arginine to l-citrulline conversion with 1-(2-trifluoromethylphenyl) imidazole (TRIM), a specific nNOS antagonist, in sub-cellular fractions; (iii) intracellular cGMP levels, as a marker for nitric oxide production, after TRIM pre-treatment, by radioimmunoassay. nNOS protein was expressed in the cytosolic fraction and immunolocalised in cultured HUVEC, and co-localised with the eNOS protein in frozen sections of the human umbilical cord. nNOS protein contributed to total l-citrulline production as TRIM selectively and dose-dependently reduced l-citrulline synthesis in the cytosolic but not particulate fraction of HUVEC. Similarly, TRIM reduced intracellular cGMP content both at baseline and after stimulation with a calcium ionophore. Cytomix down-regulated the expression and function of both nNOS and eNOS while no inducible NOS (iNOS) was detected. In conclusion, a functional neuronal type of NOS is co-expressed with the endothelial NOS type in HUVEC, suggesting a possible role for nNOS in regulation of blood flow.",
keywords = "Cell culture/isolation, Cytokines, Endothelial factors, Infection/inflammation, Nitric oxide",
author = "Tiziana Bachetti and Laura Comini and Salvatore Curello and Daniela Bastianon and Michela Palmieri and Giuliana Bresciani and Francesco Callea and Roberto Ferrari",
year = "2004",
month = "11",
doi = "10.1016/j.yjmcc.2004.07.006",
language = "English",
volume = "37",
pages = "939--945",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "5",

}

TY - JOUR

T1 - Co-expression and modulation of neuronal and endothelial nitric oxide synthase in human endothelial cells

AU - Bachetti, Tiziana

AU - Comini, Laura

AU - Curello, Salvatore

AU - Bastianon, Daniela

AU - Palmieri, Michela

AU - Bresciani, Giuliana

AU - Callea, Francesco

AU - Ferrari, Roberto

PY - 2004/11

Y1 - 2004/11

N2 - Despite originally identified in neurones, the neuronal type of nitric oxide synthase (nNOS) is present also in cardiac and skeletal myocytes. Whether nNOS is functionally expressed in human endothelial cells - as the endothelial enzyme (eNOS) - is unknown. Human umbilical vein endothelial cells (HUVEC) were studied under control culture conditions and after 48 h treatment with cytomix (human tumour necrosis factor-α, interferon-γ and E. coli endotoxin). We tested: (i) localisation and expression of nNOS and eNOS proteins by immunostaining and immunoblotting; (ii) activity of nNOS and eNOS by measuring l-arginine to l-citrulline conversion with 1-(2-trifluoromethylphenyl) imidazole (TRIM), a specific nNOS antagonist, in sub-cellular fractions; (iii) intracellular cGMP levels, as a marker for nitric oxide production, after TRIM pre-treatment, by radioimmunoassay. nNOS protein was expressed in the cytosolic fraction and immunolocalised in cultured HUVEC, and co-localised with the eNOS protein in frozen sections of the human umbilical cord. nNOS protein contributed to total l-citrulline production as TRIM selectively and dose-dependently reduced l-citrulline synthesis in the cytosolic but not particulate fraction of HUVEC. Similarly, TRIM reduced intracellular cGMP content both at baseline and after stimulation with a calcium ionophore. Cytomix down-regulated the expression and function of both nNOS and eNOS while no inducible NOS (iNOS) was detected. In conclusion, a functional neuronal type of NOS is co-expressed with the endothelial NOS type in HUVEC, suggesting a possible role for nNOS in regulation of blood flow.

AB - Despite originally identified in neurones, the neuronal type of nitric oxide synthase (nNOS) is present also in cardiac and skeletal myocytes. Whether nNOS is functionally expressed in human endothelial cells - as the endothelial enzyme (eNOS) - is unknown. Human umbilical vein endothelial cells (HUVEC) were studied under control culture conditions and after 48 h treatment with cytomix (human tumour necrosis factor-α, interferon-γ and E. coli endotoxin). We tested: (i) localisation and expression of nNOS and eNOS proteins by immunostaining and immunoblotting; (ii) activity of nNOS and eNOS by measuring l-arginine to l-citrulline conversion with 1-(2-trifluoromethylphenyl) imidazole (TRIM), a specific nNOS antagonist, in sub-cellular fractions; (iii) intracellular cGMP levels, as a marker for nitric oxide production, after TRIM pre-treatment, by radioimmunoassay. nNOS protein was expressed in the cytosolic fraction and immunolocalised in cultured HUVEC, and co-localised with the eNOS protein in frozen sections of the human umbilical cord. nNOS protein contributed to total l-citrulline production as TRIM selectively and dose-dependently reduced l-citrulline synthesis in the cytosolic but not particulate fraction of HUVEC. Similarly, TRIM reduced intracellular cGMP content both at baseline and after stimulation with a calcium ionophore. Cytomix down-regulated the expression and function of both nNOS and eNOS while no inducible NOS (iNOS) was detected. In conclusion, a functional neuronal type of NOS is co-expressed with the endothelial NOS type in HUVEC, suggesting a possible role for nNOS in regulation of blood flow.

KW - Cell culture/isolation

KW - Cytokines

KW - Endothelial factors

KW - Infection/inflammation

KW - Nitric oxide

UR - http://www.scopus.com/inward/record.url?scp=7444220194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7444220194&partnerID=8YFLogxK

U2 - 10.1016/j.yjmcc.2004.07.006

DO - 10.1016/j.yjmcc.2004.07.006

M3 - Article

VL - 37

SP - 939

EP - 945

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 5

ER -